Intellectual Property UK

  • January 13, 2025

    Driving Data Biz Sues Telematics Co. For $57M Over IP Breach

    A Swedish data analytics company confirmed that it is planning to bring a $57 million claim against its former collaborator, a Norwegian vehicle tracking business, for infringing the company's intellectual property rights after their contract ended.

  • January 13, 2025

    Water Bottle Co. Obtains Injunction Against Chinese Copycats

    A water bottle maker has secured a default judgment against a Chinese manufacturer after a European court agreed that it was selling copycat bottles that infringed patented flavor-enhancing technology.

  • January 13, 2025

    3M Gets Coating Patent Revived Over Saint-Gobain Challenge

    A European appeals panel has restored 3M's original patent over an abrasive coating amid a feud with Saint-Gobain, ruling in a decision issued Monday that the patent was valid before 3M's amendments.

  • January 13, 2025

    UK Unveils Blueprint To Become AI World Leader

    The government unveiled Monday an ambitious blueprint to make Britain a world leader in artificial intelligence to benefit financial services and other sectors, supported by pro-growth regulation.

  • January 13, 2025

    Auto Parts Makers Settle UPC Clash Over Machine Patent

    Two car parts manufacturers have settled their long-running dispute in the Unified Patent Court over intellectual property rights for electric machines, the court has confirmed.

  • January 13, 2025

    GSK To Buy US Biotech Biz IDRx For Up To $1.15B

    British pharmaceutical giant GSK PLC said Monday that it will buy Boston-based IDRx Inc. for up to $1.15 billion as it seeks to expand its portfolio of treatments for gastrointestinal cancers.

  • January 10, 2025

    Abbott Loses Appeal Over Law Firm's Access To UPC Docs

    Abbott Diabetes Care Inc. has lost its appeal against the Unified Patent Court's decision to let a law firm see documents from the company's dispute over two glucose monitor patents, with the UPC Court of Appeal ruling Thursday that there is no reason to revoke the firm's access.

  • January 10, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen legal services group RBG Holdings face a winding-up petition from founder Ian Rosenblatt amid soured talks about the group's leadership, J.P. Morgan file a fresh claim against WeRealize, retailer Asda face an intellectual property claim over a specific type of mandarin and financier Nathaniel Rothschild sue German entrepreneur Lars Windhorst and his investment vehicle Tennor International. Here, Law360 looks at these and other new claims in the U.K.

  • January 10, 2025

    Ferrero Unit's 'Dare To Combine' Candy TM Too Descriptive

    A Ferrero Group-owned candy company can't register the trademark "Dare to Combine" because it lacks originality and describes how consumers usually mix flavors, European officials have ruled.

  • January 10, 2025

    Interflora Claims Rival Flower Biz Hijacked Search Results

    A U.K. flower delivery company has accused a rival of using Google's keyword advertising scheme to divert customers when they search for "Interflora" bouquets, in breach of a decade-old agreement.

  • January 10, 2025

    Abbott, Dexcom End UPC Feud Over Glucose Monitor Patent

    Abbott and Dexcom have ended their Unified Patent Court clash over blood glucose monitoring tech just a week before the court was due to weigh in, according to a document issued Friday.

  • January 10, 2025

    Chinese Fruit Seller Sues Rival Over 'Mountain Pear' TM

    A wholesaler of Chinese fruit has hit a rival with a trademark infringement case in a London court, accusing its competitor of stealing its "Mountain Pear" and "Yu Lu Fragrant Pear" trademarks.

  • January 10, 2025

    Meril Can't Bill Third Party For Costs Of UPC Docs Request

    Meril must cover its costs of defending itself against an unsuccessful request by a third party to look at case documents from its quest to revoke a European patent for heart valves made by a U.S. medical technology company, the Unified Patent Court has ruled.

  • January 17, 2025

    Fieldfisher Hires Disputes Pro From DWF In Birmingham

    Fieldfisher LLP has hired a new dispute resolution partner to its Birmingham office from DWF LLP, with the new arrival saying Friday that he is keen to work on high-value matters that are "unheard of" at other firms in central England.

  • January 09, 2025

    Firms With IP Significantly Outperform Peers, Report Says

    Companies of all sizes that own registered intellectual property rights generally perform better than those that don't, according to a joint study between the European Union's IP office and Europe's patent authority.

  • January 09, 2025

    Norwich City Sues Gin Maker Over Celebration Bottle TM

    Norwich City Football Club has brought legal action against the owners of a spirits producer, alleging it used the club's trademarks for a gin released to celebrate the club's promotion to the Premier League after their licensing deal ended.

  • January 09, 2025

    Medical Tech Co. Founders Fairly Fired Over Misconduct

    A medical technology company was justified in firing two of its founders for misconduct after they stole valuable product information and tried to unilaterally kick a senior colleague out, an employment tribunal has ruled.

  • January 09, 2025

    UPC Rules Chip Supplier Can Intervene In Phone Co.'s Case

    MediaTek can join Xiaomi's bid to defeat a U.S. company's appeal over a decision limiting its access to confidential information, the Unified Patent Court has ruled amid the trio's ongoing infringement dispute.

  • January 09, 2025

    Vape Biz Sues Rival For 'Vapestop' TM Infringement

    A vape store has accused a rival distributor of copying its branding to take advantage of its better-cemented reputation in the market and steal potential customers away.

  • January 09, 2025

    Japanese Pharma Biz Loses Kidney Transplant Therapy Patent

    An Australian biotech company has persuaded a European appeals panel to revoke the patent of Japanese rival Takeda over a treatment for kidney transplant patients, proving it is doubtful whether the therapy has its intended effect.

  • January 09, 2025

    Ex-Lawyer Sues BT Over Lost £8M From Search Invention

    A retired real estate lawyer has accused British Telecommunications and a paralegal firm of conspiring to exclude him from a system he created to find building asset risks, alleging they robbed him of more than £8.75 million ($10.8 million) in future annual revenue.

  • January 08, 2025

    Howard Kennedy Recruits IP Partner From Gunnercooke

    Howard Kennedy LLP has recruited a new partner from Gunnercooke LLP to its intellectual property team in London, with the lawyer saying Wednesday she's ready to leave behind the "eat what you kill" model to join a more traditional setup.

  • January 08, 2025

    Cleaning Co. Loses Bid For 'OmniSan' TM

    A Romanian cleaning product company has failed to convince a European court to overturn a decision blocking it from using the trademark "OmniSan," as the court found Wednesday that the mark bore too much resemblance to another hygiene product brand.

  • January 08, 2025

    Shower Equipment Maker Sues Rival Over Pump Patent

    A company that makes modified shower equipment for people with mobility issues has accused a rival shower equipment manufacturer of infringing its patent for a type of shower pump.

  • January 08, 2025

    Zara's New Cafe Hits TM Bump Over Rival 'Zicaffè' Brand

    Just over a month since debuting its first coffee shop, Zara has hit a bump after Italian coffee brand Zicaffè filed two oppositions to nix its recently registered European Union trademarks over "Zacaffè."

Expert Analysis

  • AI Reforms Prompt Fintech Compliance Considerations

    Author Photo

    With the EU Artificial Intelligence Act's Aug. 1 enforcement, and the U.K.'s new plans to introduce AI reforms, fintech companies should consider how to best focus limited resources as they balance innovation and compliance, says Nicola Kerr-Shaw at Skadden.

  • 10 Ways To Manage AI Risks In Service Contracts

    Author Photo

    With the European Union Artificial Intelligence Act coming into force on Aug. 1 and introducing a new regulatory risk, and with AI technology continuing to develop at pace, parties to services arrangements should employ mechanisms now to build in flexibility and get on the front foot, says James Longster at Travers Smith.

  • What Future May Hold For AI Innovation In UK Under Labour

    Author Photo

    Labour’s recent King's Speech was notable in its absence of discussion of a comprehensive artificial intelligence bill, and while this may indicate to many that the UK is open for business, the party’s approach to cross-sectoral engagement will be critical for shaping Britain's AI landscape in the near term, says Alexander Amato-Cravero at Herbert Smith.

  • Don't Wing Settlements: Lessons From Morley's TM Ruling

    Author Photo

    In Morley's v. Sivakumar, the Intellectual Property Enterprise Court recently found that a fast-food franchiser had breached a fried chicken franchise's trademark rights, despite a prior settlement agreement, offering lessons on drafting express terms to ensure IP protection, say Nessa Khandaker and Clare Cornell at Finnegan.

  • Use Or Lose It: European TM Ruling Stresses 'Genuine Use'

    Author Photo

    The European Union General Court recently dismissed an action to revoke trademark protections for a lack of use in Sta Grupa v. EU Intellectual Property Office, offering significant insight into the intricacies of assessing evidence of genuine use in revocation actions, says Sumi Nadarajah at FRKelly.

  • 1 Year At The UPC: Implications For Transatlantic Disputes

    Author Photo

    In its first year, the Unified Patent Court has issued important decisions on procedures like provisional measures, but complexities remain when it comes to coordinating proceedings across jurisdictions like the U.S. due to differences in timelines and discovery practices, say attorneys at McDermott.

  • Trends, Tips From 7 Years Of EPO Antibody Patent Appeals

    Author Photo

    Recent years of European Patent Office decisions reveal some surprising differences between appeals involving therapeutic antibody patents and those for other technologies, offering useful insight into this developing area of European case law for future antibody patent applicants, say Alex Epstein and Jane Evenson at CMS.

  • Companies Trading In The EU Should Heed Mondelēz Ruling

    Author Photo

    The European Commission’s recent €337.5 million fine of Mondelēz is the latest decision targeting restrictions on EU cross-border trade, and serves as a warning to companies active in the region to check their contracts and practices for illegal restraints, and to perform audits to ensure compliance, says Matthew Hall at McGuireWoods.

  • 4 Takeaways From Biotech Patent Invalidity Ruling

    Author Photo

    The recent Patents Court decision in litigation between Advanced Cell Diagnostics and Molecular Instruments offers noteworthy commentary on issues related to experiments done in the ordinary course of business, joint importation, common general knowledge and mindset, and mosaicking for anticipation, say Nessa Khandaker and Darren Jiron at Finnegan.

  • How Life Science Companies Are Approaching UPC Opt-Outs

    Author Photo

    A look at recent data shows that one year after its launch, the European Union's Unified Patent Court is still seeing a high rate of opt-outs, including from large U.S.-based life science companies wary of this unpredictable court — and there are reasons this strategy should largely remain the same, say Sanjay Murthy and Christopher Tuinenga at McAndrews Held.

  • Lego Ruling Builds Understanding Of Design Exam Process

    Author Photo

    In Lego v. Guangdong Loongon, the European Union Intellectual Property Office recently invalidated a registered design for a toy figure, offering an illustrative guide to assessing the individual character of a design in relation to a preexisting design, says Christoph Moeller at Mewburn Ellis.

  • Protecting Trade Secrets In US, EU Gov't Agency Submissions

    Author Photo

    Attorneys at Mintz compare U.S. and European Union trade secret laws, and how proprietary information in confidential submissions to the U.S. Food and Drug Administration and the European Medicines Agency is protected in the face of third-party information requests under government transparency laws.

  • The Unified Patent Court: What We Learned In Year 1

    Author Photo

    ​​​​​​​The Unified Patent Court celebrated its first anniversary this month, and while questions remain as we wait for the first decisions on the merits, a multitude of decisions and orders regarding provisional measures and procedural aspects have provided valuable insights already, says Antje Brambrink at Finnegan.

  • F1 Driver AI Case Sheds Light On Winning Tactics In IP Suits

    Author Photo

    A German court recently awarded damages to former F1 driver Michael Schumacher's family in an artificial intelligence dispute over the unlicensed use of his image, illustrating how athletes are using the law to protect their brands, and setting a precedent in other AI-generated image rights cases, William Bowyer at Lawrence Stephens.

  • Cos. Increasingly Must Protect And Manage Intangible Assets

    Author Photo

    As investors increasingly reward companies for their institutional knowledge and intellectual capital, there is a growing urgency for organizations — especially their chief legal officers — to identify, protect and fully realize the value of intangible assets, says Paul Garland at Deloitte.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!